Novel longitudinal Multiple Overall Toxicity (MOTox) score to quantify adverse events experienced by patients during chemotherapy treatment: a retrospective analysis of the MRC BO06 trial in osteosarcoma

Author(s):
Spreafico, M. (0000-0002-7773-9976); Ieva, F.; Arlati, F.; Capello, F.; Fatone, F.; Fedeli, F.; Genalti, G.; Anninga, J.; Gelderblom, H.; Fiocco, M.
Published
2021
Publication type
Article / Letter to editor
Date issued
2021
Language
English
Publisher
BMJ
Is part of
BMJ Open (2021), No. 12
hdl
1887/3275410
doi
10.1136/bmjopen-2021-053456